The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction,...
This is a purchase order contract awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Norgen Biotek Corp, a Canadian for-profit manufacturer of biotechnology products and services. The contract, valued at $149,840, is for the provision of exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at NIH. Norgen Biotek has previously been awarded over $1 million in...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $16,821.83 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosomal RNA purification services. This order, which does not have a set-aside designation, supports unspecified NIDDK and National Heart, Lung and Blood Institute clinical trials, as well as future RNA sequencing work for the National Human Genome Research Institute (NHGRI). Norgen Biotek...
This is a $37,814 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. The contract is for the extraction of total RNA from whole blood samples in support of research activities at the National Human Genome Research Institute (NHGRI), another NIH agency. The contract was awarded on July 10, 2020 through full and open competition, with a period of performance ending on March 31,...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $11,475 firm fixed-price purchase order to Innomics Inc., a for-profit corporation that provides genomic sequencing and bioinformatics services to the federal government. The contract is for the acquisition of exosome lysis and protein recovery services. Innomics Inc. has a history of providing DNA/RNA sequencing, sequence analysis, and...
This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $82,344.00, is for the procurement of 10X Genomics Chromium Single Cell 3' Library and Gel Bead Kit V2 products and services. 10X Genomics, Inc., a for-profit manufacturer, is the prime contractor. The contract does not utilize a set-aside designation. The...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
The National Institute of Environmental Health Sciences (NIEHS), a civilian agency, awarded a firm fixed price purchase order contract worth $65,845 to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms and consumables. The contract, which does not have a set-aside designation, is for single-cell sequencing and spatial transcriptomics products and services to support biomedical research efforts across various scientific domains, including infectious diseases,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...